Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous Revision: v3.4.2. This is a minor site version update and does not alter study content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision log updated: added v3.4.2 and removed v3.4.1.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.4.1 added and v3.4.0 removed; this is a minor frontend version update with no apparent changes to study details or user interactions.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a 'Show glossary' option and updated QC-related labels to reflect the latest submission and revision version, with older QC labels removed.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded the 'Last Update Posted' field and removed the 'Last Update Posted (Estimated)' field; this metadata change does not affect study details, eligibility, or outcomes.SummaryDifference0.0%

Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.